-

Sommetrics Presents at 22nd Annual Needham Virtual Healthcare Conference

SAN DIEGO, Calif.--(BUSINESS WIRE)--Sommetrics, a private company developing solutions to improve sleep health by providing innovative first in class products to treat sleep apnea, today announced that it made a presentation at the 22nd Annual Needham Virtual Healthcare Conference. The presentation highlighted the Company’s aerSleep II system for the treatment of moderate and severe sleep apnea and described progress in the U.S. pivotal SUPRA trial (Study Using negative Pressure to Relieve Apnea). A video archive of the presentation may be found at https://wsw.com/webcast/needham129/somm/2278536.

About Sommetrics

Sommetrics is a privately funded company located in San Diego, California. It is focused on improving sleep quality by providing products and services that deal with disorders of the upper airway such as obstructive sleep apnea (OSA) and snoring. For more information, visit www.sommetrics.com.

Contacts

Cory Lancaster
SVP Finance/Investor Relations
760 295 5620
info@sommetrics.com
www.sommetrics.com

Industry:

Sommetrics

Release Versions
English

Contacts

Cory Lancaster
SVP Finance/Investor Relations
760 295 5620
info@sommetrics.com
www.sommetrics.com

More News From Sommetrics

John Frank an Industry Leader in Sleep and Respiratory Care Joins the Sommetrics Board of Directors

SAN DIEGO--(BUSINESS WIRE)--Sommetrics, a private company developing solutions to improve sleep health by providing innovative first in class products to treat sleep apnea, today announced that Mr. John Frank was elected to its Board of Directors. Mr. Frank has over three decades of experience and a successful track record of developing innovative solutions and world class organizations across ambulatory, home care and hospital segments. As Sr. Executive and Business Group Leader at Philips, he...

Sommetrics Presents Update on Pivotal SUPRA Sleep Apnea Trial at International Sleep and Breathing Conference

SAN DIEGO--(BUSINESS WIRE)--Sommetrics, a private company developing products and services to improve sleep health, today announced presentation of an interim update on its pivotal SUPRA study (Study Using Negative Pressure to Reduce Apnea) at the tri-annual, XVII International Symposium on Sleep and Breathing in Auckland, New Zealand. The presenter was Dr. Kingman Strohl, Program Director, Sleep Medicine, University Hospital, Cleveland, and Professor of Medicine, Case School of Medicine; he is...

Sommetrics Provides Update on the Pivotal SUPRA Clinical Trial for Sleep Apnea and Recent Corporate Accomplishments

VISTA, Calif.--(BUSINESS WIRE)--Sommetrics, a private company developing products and services to improve sleep health, today released an update on its key accomplishments during the first quarter of 2022. Chief among these accomplishments was the Company’s advancing clinical activities aimed at obtaining FDA market clearance for its flagship product, aerSleep® II, that is targeted for the treatment of obstructive sleep apnea in those unable to use standard therapy with continuous positive airw...
Back to Newsroom